Mechanism of anti-inflammatory action of glucocorticoids: re-evaluation of vascular constriction hypothesis.

Por Sugio, K., Tsurufuji, S.
Publicado em 1981

Vascular permeability responses and the role of prostaglandin E2 in an experimental allergic inflammation of air pouch type in rats.

Por Hirasawa, N., Ohuchi, K., Sugio, K., Tsurufuji, S., Watanabe, M., Yoshino, S.
Publicado em 1986

K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer.

Por Fukuyama, Y., Mitsudomi, T., Sugio, K., Ishida, T., Akazawa, K., Sugimachi, K.
Publicado em 1997

Sodium‐glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low‐carbohydrate diet

Por Nishimura, R., Omiya, H., Sugio, K., Ubukata, M., Sakai, S., Samukawa, Y.
Publicado no Diabetes Obes Metab (2016)

Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabe...

Por Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., Samukawa, Y.
Publicado no Diabetes Obes Metab (2015)

Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence

Por Gu, C, Oyama, T, Osaki, T, Li, J, Takenoyama, M, Izumi, H, Sugio, K, Kohno, K, Yasumoto, K
Publicado em 2004

Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking

Por Sugio, K, Uramoto, H, Ono, K, Oyama, T, Hanagiri, T, Sugaya, M, Ichiki, Y, So, T, Nakata, S, Morita, M, Yasumoto, K
Publicado em 2006